„First Line“

Suchergebnisse

3.416 Treffer

• Challenges to replace ACT as first-line drug
  Phyo, Aung Pyae ; Seidlein, Lorenz von
• Recurrent glioblastomas in the elderly after maximal first-line treatment: does preserved overall condition warrant a maximal second-line treatment?
  Zanello, Marc ; Roux, Alexandre ; Ursu, Renata ; Peeters, Sophie ; Bauchet, Luc ; Noel, Georges ; Guyotat, Jacques ; Le Reste, Pierre-Jean ; Faillot, Thierry ; Litre, Fabien ; Desse, Nicolas ; Emery, Evelyne ; Petit, Antoine ; Peltier, Johann ; Voirin, Jimmy ; Caire, François ; Barat, Jean-Luc ; Vignes, Jean-Rodolphe ; Menei, Philippe ; Langlois, Olivier ; Dezamis, Edouard ; Carpentier, Antoine ; Dam Hieu, Phong ; Metellus, Philippe ; Pallud, Johan
• Phase I/II study of bi-weekly XELIRI plus bevacizumab treatment in patients with metastatic colorectal cancer resistant to oxaliplatin-based first-line chemotherapy
  Mizushima, Tsunekazu ; Fukunaga, Mutsumi ; Sueda, Toshinori ; Ikeda, Masataka ; Kato, Takeshi ; Kim, Ho Min ; Kudo, Toshihiro ; Murata, Kohei ; Nishimura, Junichi ; Hata, Taishi ; Matsuda, Chu ; Yamamoto, Hirofumi ; Doki, Yuichiro ; Mori, Masaki
• Phenotypic and genotypic susceptibility testing of M tuberculosis
  Atanda, Oluwasegun 2017 LAP LAMBERT Academic Publishing
• A prospective study of XELIRI plus bevacizumab as a first-line therapy in Japanese patients with unresectable or recurrent colorectal cancer (KSCC1101)
  Ando, Koji ; Emi, Yasunori ; Suenaga, Toyokuni ; Hamanoue, Masahiro ; Maekawa, Soichiro ; Sakamoto, Yasuo ; Kai, Seiichiro ; Satake, Hironaga ; Shimose, Takayuki ; Shimokawa, Mototsugu ; Saeki, Hiroshi ; Oki, Eiji ; Sakai, Kenji ; Akagi, Yoshito ; Baba, Hideo ; Maehara, Yoshihiko
• Factors associated with pre-treatment HIV RNA: application for the use of abacavir and rilpivirine as the first-line regimen for HIV-infected patients in resource-limited settings
  Kiertiburanakul, Sasisopin ; Boettiger, David ; Ng, Oon Tek ; Kinh, Nguyen Van ; Merati, Tuti Parwati ; Avihingsanon, Anchalee ; Wong, Wing-Wai ; Lee, Man Po ; Chaiwarith, Romanee ; Kamarulzaman, Adeeba ; Kantipong, Pacharee ; Zhang, Fujie ; Choi, Jun Yong ; Kumarasamy, Nagalingeswaran ; Ditangco, Rossana ; Cuong, Do Duy ; Oka, Shinichi ; Sim, Benedict Lim Heng ; Ratanasuwan, Winai ; Ly, Penh Sun ; Yunihastuti, Evy ; Pujari, Sanjay ; Ross, Jeremy L. ; Law, Matthew ; Sungkanuparph, Somnuek
• Should Ablation Be First-Line Therapy for Patients with Paroxysmal AF?
  Conti, Sergio ; Verma, Atul
• Längeres Überleben mit einer Kombinationstherapie first line?
  Rexer, Heidrun ; Steiner, Thomas ; Bergmann, Lothar
• Anti-EGFR and Anti-VEGF Agents in First-Line Therapy for Advanced Colorectal Cancer
  Mitchell, Aaron P. ; Sanoff, Hanna K.
• Trial-level analysis of progression-free survival and response rate as end points of trials of first-line chemotherapy in advanced ovarian cancer
  Colloca, Giuseppe ; Venturino, Antonella
• The Updated NICE Guidelines: Cardiac CT as the First-Line Test for Coronary Artery Disease
  Moss, Alastair J. ; Williams, Michelle C. ; Newby, David E. ; Nicol, Edward D.
• Childhood Acute Lymphoblastic Leukemia
  Vora, Ajay 2017 Springer International Publishing
• Gemcitabine in Combination with a Second Cytotoxic Agent in the First-Line Treatment of Locally Advanced or Metastatic Pancreatic Cancer: a Systematic Review and Meta-Analysis
  Zhang, Xiu-Wei ; Ma, Yu-Xiang ; Sun, Yang ; Cao, Yu-Bo ; Li, Qin ; Xu, Chong-An
• Multicenter, randomized, open-label Phase II study comparing S-1 alternate-day oral therapy with the standard daily regimen as a first-line treatment in patients with unresectable advanced pancreatic cancer
  Yamaue, Hiroki ; Shimizu, Atsushi ; Hagiwara, Yasuhiro ; Sho, Masayuki ; Yanagimoto, Hiroaki ; Nakamori, Shoji ; Ueno, Hideki ; Ishii, Hiroshi ; Kitano, Masayuki ; Sugimori, Kazuya ; Maguchi, Hiroyuki ; Ohkawa, Shinichi ; Imaoka, Hiroshi ; Hashimoto, Daisuke ; Ueda, Kazuki ; Nebiki, Hiroko ; Nagakawa, Tatsuya ; Isayama, Hiroyuki ; Yokota, Isao ; Ohashi, Yasuo ; Shirasaka, Tetsuhiko
• Erstlinientherapie beim fortgeschrittenen Nierenzellkarzinom – Eine randomisierte, offene Phase-III-Studie zur Beurteilung der Wirksamkeit und Sicherheit von Pembrolizumab (MK-3475) in Kombination mit Axitinib im Vergleich zu einer Sunitinib-Monotherapie als First-line-Behandlung bei lokal fortgeschrittenem oder metastasiertem Nierenzellkarzinom (mRCC) (Keynote-426) – AN 39/16 der AUO
  Rexer, H. ; Bedke, J.
• Positive relationship between subsequent chemotherapy and overall survival in pancreatic cancer: meta-analysis of postprogression survival for first-line chemotherapy
  Kasuga, Akiyoshi ; Hamamoto, Yasuo ; Takeuchi, Ayano ; Kawasaki, Kenta ; Suzuki, Takeshi ; Hirata, Kenro ; Sukawa, Yasutaka ; Takaishi, Hiromasa ; Kanai, Takanori
• Uterine Artery Embolization for Retained Products of Conception with Marked Vascularity: A Safe and Efficient First-Line Treatment
  Bazeries, Paul ; Paisant-Thouveny, Francine ; Yahya, Sultan ; Bouvier, Antoine ; Nedelcu, Cosmina ; Boussion, Francoise ; Sentilhes, Loic ; Willoteaux, Serge ; Aubé, Christophe
• First-Line Disease-Modifying Therapies in Paediatric Multiple Sclerosis – A Comprehensive Overview
  Johnston, Jessica ; So, Tsz-Yin
• Successes and failures: what did we learn from recent first-line treatment immunotherapy trials in non-small cell lung cancer?
  Remon, Jordi ; Besse, Benjamin ; Soria, Jean-Charles
• First-line screening tests for Cushing’s syndrome in patients with adrenal incidentaloma: the role of urinary free cortisol measured by LC-MS/MS
  Ceccato, F. ; Antonelli, g. ; Frigo, A. C. ; Regazzo, D. ; Plebani, M. ; Boscaro, M. ; Scaroni, C.